Status:
TERMINATED
Function and Composition of Regulatory B Cells in Participants With Glioblastoma
Lead Sponsor:
Amsterdam UMC, location VUmc
Conditions:
Glioblastoma, Adult
Eligibility:
All Genders
18+ years
Brief Summary
Rationale: This project elaborates on a novel finding of the investigators that has not yet been reported in literature, namely the presence of elevated levels of atypical B cells in participants with...
Eligibility Criteria
Inclusion
- Clinical diagnosis Glioblastoma Patients are 18 years or older at first diagnosis
Exclusion
- No indication for surgery to confirm radiological diagnosis Not able or willing to give informed consent Allergy or intolerance to dexamethasone
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 20 2024
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04128774
Start Date
January 1 2021
End Date
November 20 2024
Last Update
November 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amsterdam Medical Universities
Amsterdam, North Holland, Netherlands, 1081HV